Role of Angiotensin and Its Inhibition in Hypertension, Ischemic Heart Disease, and Heart Failure
Author(s) -
Haralambos Gavras,
Hans R. Brunner
Publication year - 2001
Publication title -
hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.986
H-Index - 265
eISSN - 1524-4563
pISSN - 0194-911X
DOI - 10.1161/01.hyp.37.2.342
Subject(s) - heart failure , medicine , angiotensin ii , blockade , pathogenesis , renin–angiotensin system , cardiology , disease , clinical trial , hemodynamics , angiotensin receptor , angiotensin ii receptor type 1 , animal studies , blood pressure , receptor
This is a personal historical account relating the events that led to the first application of angiotensin inhibition (either by ACE inhibitors or by angiotensin receptor blockade) to the investigation of the pathogenesis and treatment of hypertension, ischemic heart disease, and heart failure. Included are animal experiments, clinical observations, and the earliest clinical experimental studies that helped define some of the detrimental effects of angiotensin II and the beneficial hemodynamic results of its inhibition, which have been subsequently corroborated and amplified by large randomized outcome trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom